SATS Ltd - Brace, brace

17 Feb 2020
  • 3QFY20 revenue was better than expected. Earnings missed due to weaker margins. EBIT margins impacted by cargo weakness, increased IT expenses and higher contribution of newly consolidated Country Foods.
  • Associate earnings fell due to start-up losses at new Daxing operations and exclusion of prior year gain on of sale of S$5.8mn from DFASS to KrisShop.
  • The outlook is uncertain with the outbreak of COVID-19 virus. SATS revenue will suffer from the dip in aviation traffic and closure of restaurants in China. Our FY20e PATMI is cut by 23%. As a gauge of the impact, the Singapore Tourism Board mentioned a possible 25-30% fall in visitor arrivals in 2020 due to the outbreak.
  • Downgrade to NEUTRAL from ACCUMULATE with a lower target price of $4.45 (prev. S$5.36). Excluding the acquisition, core revenues were flat. We think SATS will require some time to recover from the depressed volumes triggered by COVID-19 virus and to grow the organic earnings of their recent acquisitions

 

The Positives

+ Revenue better than expected due to acquisition. Revenue jump of 17% YoY in 3Q20 was entirely due to consolidation of Country Food and acquisition of Ground Team Red (GTR) and Nanjing Weizhou. Core revenue would have been flat excluding the acquisitions.

+ Japan to grow even faster. Revenue from Japan rose 10.6% YoY in 3Q20 to S$70.5mn. It is the 3rd largest geography for SATS after Singapore (contributes S$432.6mn or 60% of Group revenue) and Greater China (S$97.2mn or 13.6% of group revenue). SATS has invested in sufficient capacity to benefit from increased slots at the Haneda airport.          

The Negatives

– Core EBIT margins depressed. When we exclude the acquisition, EBIT would have dropped around 9.6% to S$59mn. The new entities contributed around S$3.9mn incremental EBIT, from our estimates. This is reflected by Singapore PATMI falling 14.2% YoY in 3Q20 despite a 4% improvement in revenues.

 

Outlook

We see multiple near-term challenges ahead for SATS. Even before the outbreak, core earnings in Singapore was weak due to soft cargo volumes, possible lower pricing and higher expenses. The situation is exacerbated the virus outbreak, affecting other parts of the business, namely passenger traffic in all airports and food business in China.

 

Downgrade to NEUTRAL from ACCUMULATE; Lower target price of $4.45

We slash our FY20 earnings by 23%. Our lower target price is due to the cut in earnings, reduced terminal growth to 1% and cost of equity raised to 8% in view of the increased uncertainty and risk surrounding the current environment. This pegs SATS to 19x PE FY21e.

About the author

Paul Chew
Head of Research
Phillip Securities Research Pte Ltd

Paul has 20 years of experience as a fund manager and sell-side analyst. During his time as fund manager, he has managed multiple funds and mandates including capital guaranteed, dividend income, renewable energy, single country and regionally focused funds.

He graduated from Monash University and had completed both his Chartered Financial Analyst and Australian CPA programme.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com